North America Human Leukocyte Antigens (HLAs) Typing Transplant Diagnostics Services Market – Industry Trends and Forecast to 2029

Inhaltsverzeichnis anfordernInhaltsverzeichnis anfordern Mit Analyst sprechen Mit Analyst sprechen Jetzt kaufenJetzt kaufen Vor dem Kauf anfragen Vorher anfragen Kostenloser Beispielbericht Kostenloser Beispielbericht

North America Human Leukocyte Antigens (HLAs) Typing Transplant Diagnostics Services Market – Industry Trends and Forecast to 2029

  • Medical Devices
  • Upcoming Reports
  • Jan 2022
  • North America
  • 350 Seiten
  • Anzahl der Tabellen: 220
  • Anzahl der Abbildungen: 60

North America Hla Typing Transplant Diagnostics Services Market

Marktgröße in Milliarden USD

CAGR :  % Diagram

Diagramm Prognosezeitraum
2023 –2029
Diagramm Marktgröße (Basisjahr)
MILLIONEN USD
Diagramm Marktgröße (Prognosejahr)
MILLIONEN USD
Diagramm CAGR
%
Diagramm Wichtige Marktteilnehmer
  • Johnson & Johnson Private Limited
  • Siemens
  • BD
  • Thermo Fischer Scientific
  • QIAGEN

North America Human Leukocyte Antigens (HLAs) Typing Transplant Diagnostics Services Market, By Product and Services (Instruments, Reagents and Consumables, Software, Services), Application (Diagnostics, Research), End-user (Hospitals, Academic and Research Institutes), Organ Type (Kidney, Liver, Heart, Lung, Pancreas, Others), Technology (Polymerase Chain Reaction, Next-Generation Sequencing), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029.

North America Human Leukocyte Antigens (HLAs) Typing Transplant Diagnostics Services Market

Market Analysis and Insights of Human Leukocyte Antigens (HLAs) Typing Transplant Diagnostics Services Market

Human leukocyte antigens (HLAs) typing transplant diagnostics services market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses the market to grow at a CAGR of 8.75% in the above-mentioned forecast period.

Human leukocyte antigen (HLA) typing transplant diagnostics is basically utilized to match patients and donors for bone marrow or cord blood transplants. HLA are the proteins or markers found on most cells in your body. The immune system uses these markers to recognize which cells belong in your body and which do not.

The growing burden of infectious diseases, rising public-private funding for target research activities and rising number of solid organ and stem cell transplantation procedures are the significant factors responsible for driving the growth of the human leukocyte antigens (HLAs) typing transplant diagnostics services market in the above-mentioned forecast period. Additionally, the rising number of drug discovery activities, the growing number of transplant procedures and increasing applications in tissue engineering, regenerative medicine and oncology research also heighten the overall growth of the market. However, the increased costs of molecular tests used for HLA typing procedures and limited reimbursements for target procedures obstruct the market’s growth.

The technological advancements in the field of HLA typing are expected to generate profitable opportunities for the market. On the other hand, the rising significant gap between the number of organ donors and organs required annually have the potential to challenge for the market’s growth.

This human leukocyte antigens (HLAs) typing transplant diagnostics services market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research human leukocyte antigens (HLAs) typing transplant diagnostics services market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

North America Human Leukocyte Antigens (HLAs) Typing Transplant Diagnostics Services Market Scope and Market Size

Human leukocyte antigens (HLAs) typing transplant diagnostics services market is segmented on the basis of product and services, application, end-user, organ type and technology. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of product and services, the human leukocyte antigens (HLAs) typing transplant diagnostics services market is segmented into instruments, reagents and consumables, software and services.
  • On the basis of application, the human leukocyte antigens (HLAs) typing transplant diagnostics services market is segmented into diagnostics and research.
  • On the basis of end-user, the human leukocyte antigens (HLAs) typing transplant diagnostics services market is segmented into hospitals, and academic and research institutes.
  • On the basis of organ type, the human leukocyte antigens (HLAs) typing transplant diagnostics services market is segmented into kidney, liver, heart, lung, pancreas and others.
  • The human leukocyte antigens (HLAs) typing transplant diagnostics services market is also segmented on the basis of technology into polymerase chain reaction and next-generation sequencing. Polymerase chain reaction is further segmented into PCR-SSP, PCR SSOP and PCR-SBT.

Human Leukocyte Antigens (HLAs) Typing Transplant Diagnostics Services Market Country Level Analysis

Human leukocyte antigens (HLAs) typing transplant diagnostics services market is segmented on the basis of product and services, application, end-user, organ type and technology.

The countries covered in the human leukocyte antigens (HLAs) typing transplant diagnostics services market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

U.S. and Canada dominates the market in North America due to increase in the prevalence of chronic diseases such as cancer, cardiac, and renal associated diseases.

The country section of the human leukocyte antigens (HLAs) typing transplant diagnostics services market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

Human leukocyte antigens (HLAs) typing transplant diagnostics services market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for human leukocyte antigens (HLAs) typing transplant diagnostics services market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the human leukocyte antigens (HLAs) typing transplant diagnostics services market. The data is available for historic period 2010 to 2020.

Competitive Landscape and Human Leukocyte Antigens (HLAs) Typing Transplant Diagnostics Services Market Share Analysis

Human leukocyte antigens (HLAs) typing transplant diagnostics services market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, North America presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to human leukocyte antigens (HLAs) typing transplant diagnostics services market.

Some of the major players operating in the human leukocyte antigens (HLAs) typing transplant diagnostics services market report are Johnson & Johnson Private Limited, Siemens, BD., Thermo Fischer Scientific., QIAGEN, ProImmune Ltd., Creative Biolabs., HistoGenetics LLC, UCLA Health, Quick Biology Inc., TBG Diagnostics Limited., Fujirebio, Medtronic, Omixon Inc., Takara Bio Inc., Biofortuna Limited, Luminex Corporation., Hologic, Inc., F. Hoffmann-La Roche Ltd., and Bio-Rad Laboratories, Inc., among others.


SKU-

Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud

  • Interaktives Datenanalyse-Dashboard
  • Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
  • Zugriff für Research-Analysten für Anpassungen und Abfragen
  • Konkurrenzanalyse mit interaktivem Dashboard
  • Aktuelle Nachrichten, Updates und Trendanalyse
  • Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Demo anfordern

Forschungsmethodik

Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.

Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.

Anpassung möglich

Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.

Häufig gestellte Fragen

U.S. and Canada dominates the market in North America due to increase in the prevalence of chronic diseases such as cancer, cardiac, and renal associated diseases.
The growth rate of the North America human leukocyte antigens (hlas) typing transplant diagnostics services market is 8.75% by 2030.
The growing burden of infectious diseases, rising public-private funding for target research activities and rising number of solid organ and stem cell transplantation procedures are the growth drivers of the North America human leukocyte antigens (hlas) typing transplant diagnostics services market.
Product and services, application, end-user, organ type, and technology are the factors on which the North America human leukocyte antigens (hlas) typing transplant diagnostics services market research is based.
Major companies in the human leukocyte antigens (HLAs) typing transplant diagnostics services market report are Johnson & Johnson Private Limited, Siemens, BD., Thermo Fischer Scientific., QIAGEN, ProImmune Ltd., Creative Biolabs., HistoGenetics LLC, UCLA Health, Quick Biology Inc., TBG Diagnostics Limited., Fujirebio, Medtronic, Omixon Inc., Takara Bio Inc., Biofortuna Limited, Luminex Corporation., Hologic, Inc., F. Hoffmann-La Roche Ltd., and Bio-Rad Laboratories, Inc.